Roche

Roche and Temedica Pilot Digital Companion for MS Patients
BioSpace
Wed, 09/15/21 - 10:18 pm
Roche
Temedica
MS
multiple sclerosis
devices
mobile apps
From Pfizer to Argenx: A look at potential blockbusters awaiting FDA decisions this year
Fierce Pharma
Mon, 09/13/21 - 11:38 pm
FDA
Pfizer
Argenx
UCB Pharma
Roche
efgartigimod
bimekizumab
faricimab
abrocitinib
Novo Nordisk, Roche see outsized threats from U.S. drug pricing talks: analysts
Fierce Pharma
Mon, 09/13/21 - 10:41 am
Novo Nordisk
Roche
drug pricing
Biotech's 'founding father' and influential deal broker Fred Frank dies at 89
Endpoints
Mon, 09/13/21 - 10:31 am
Fred Frank
Roche
Genentech
biotech
Roche dives further into cancer cell therapy with Adaptimmune deal
Pharmaforum
Tue, 09/7/21 - 10:57 am
Roche
cell therapy
cancer
Adaptimmune Therapeutics
Roche, hoping to move on from recent failure, pens $190M NeuExcell Huntington's disease pact
Fierce Biotech
Tue, 09/7/21 - 10:55 am
Roche
Huntington's disease
NeuExcell
Roche to withdraw US accelerated approval for Tecentriq to treat breast cancer
Pharmaceutical Business Review
Mon, 08/30/21 - 10:42 am
Roche
Tecentriq
Abraxane
triple negative breast cancer
FDA
accelerated approval
Roche pulls Tecentriq breast cancer nod after post-approval trial flop
Fierce Pharma
Sat, 08/28/21 - 09:04 pm
Roche
Tecentriq
breast cancer
triple negative breast cancer
postmarketing studies
Mega $3 Billion+ Deal Shapes Up for Roche to Target AD and Parkinson's
BioSpace
Tue, 08/24/21 - 11:12 am
Roche
Shape Therapeutics
RNA editing
RNAfix
Alzheimer's disease
Parkinson's Disease
Roche's Arthritis Drug, Used As COVID-19 Treatment, Faces Supply Shortage
Benzinga
Tue, 08/17/21 - 10:16 am
Roche
Actemra
COVID-19
drug shortages
J&J, Amgen and Roche face growing biosimilar competition that is driving down prices: report
Fierce Pharma
Thu, 08/12/21 - 11:04 pm
JNJ
Amgen
Roche
biosimilars
drug pricing
Roche sets bar in early lymphoma treatment with Polivy study results
BioPharma Dive
Tue, 08/10/21 - 11:23 pm
Roche
Polivy
lymphoma
On a quest to treat newly diagnosed lymphoma patients, Roche teases positive pivotal data
Endpoints
Mon, 08/9/21 - 11:07 am
Roche
Polivy
diffuse large B-cell lymphoma
FDA starts review of Roche’s eye disease drug, setting up 2022 verdict
Pharmaforum
Thu, 07/29/21 - 10:57 pm
Roche
faricimab
bispecific antibodies
diabetic macular edema
wet age-related macular degeneration
How AbbVie Could Make an Entry Into This Rapidly Growing Drug Market
Motley Fool
Thu, 07/29/21 - 11:12 am
AbbVie
Roche
Venclexta
MDS
breakthrough therapy
Roche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readout
Pharmaforum
Thu, 07/22/21 - 11:05 am
Roche
FDA
Alzheimer's disease
gantenerumab
Roche takes the Tim-3 battle to Novartis
EP Vantage
Thu, 07/22/21 - 10:53 am
Roche
sabatolimab
Novartis
RG7769
bispecific antibodies
AbbVie, Roche top data transparency list, but more could be done to build trust in medical system: report
Fierce Biotech
Wed, 07/21/21 - 10:56 am
clinical trials
clinical trial transparency
AbbVie
Roche
Novartis may have the most new drug approvals, but Roche, Lilly and AbbVie's launches win on value: report
Fierce Pharma
Thu, 07/15/21 - 12:39 pm
Novartis
AbbVie
GSK
Roche
Eli Lilly
AstraZeneca
FDA
drug launches
drug approvals
Late-Stage Clinical Study Readouts Biotech Investors Should Watch
Motley Fool
Sun, 07/11/21 - 11:13 pm
clinical trials
Novartis
Biogen
SAGE Therapeutics
uniQure
Pfizer
Roche

Pages